Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 11 M11.31 M11.5 M13.19 M14.2 M13.49 M 52.38 M Research & development —————— — Operating income -903 K-933 K-923 K44.99 M45.11 M47.83 M 137 M Non-Operating Income, Total 2.99 M1.44 M1.74 M1.36 M-814 K134 K 2.42 M Interest expense, net of interest capitalized 16.71 M16.94 M12.87 M18.36 M18.57 M19.03 M 68.83 M Non-Operating Income, excl. Interest Expenses -13.72 M-15.5 M-11.13 M-16.99 M-19.39 M-18.9 M -66.4 M Unusual income/expense —————— — Pretax income 18.3 M17.1 M19.87 M19.68 M15.87 M18.45 M 73.87 M Equity in earnings —————— — Taxes 4.37 M3.96 M4.8 M4.64 M3.85 M4.2 M 17.5 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 13.93 M13.14 M15.06 M15.04 M12.02 M14.25 M 56.37 M Discontinued operations —————— — Net income 13.93 M13.14 M15.06 M15.04 M12.02 M14.25 M 56.37 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 13.93 M13.14 M15.06 M15.04 M12.02 M14.25 M 56.37 M Basic earnings per share (Basic EPS) 0.840.790.910.910.740.87 3.43 Diluted earnings per share (Diluted EPS) 0.820.780.890.920.730.87 3.41 Average basic shares outstanding 16.67 M16.58 M16.59 M16.58 M16.35 M16.29 M — Diluted shares outstanding 16.93 M16.8 M16.84 M16.77 M16.44 M16.37 M — EBITDA 27.39 M27.02 M32.83 M27.13 M26.47 M28.94 M 115.37 M EBIT 26.88 M26.43 M32.28 M25.67 M25.58 M28 M 111.53 M Cost of revenue 16 K18 K236 K-3 000221 K91 K 545 K Other cost of goods sold —————— — Depreciation & amortization (cash flow) 511 K587 K547 K1.46 M892 K942 K 3.84 M